|
Roll up for Japan’s medical mystery tour
By David Pilling Published: November 4 2009 20:04 | Last updated: November 4 2009 20:04 Outside the sumo ring, obesity is not the most pressing problem in generally snake-hipped Japan. It is thus symbolic of Japan’s pharmaceutical industry that Takeda should this week have struck a deal with Amylin Pharmaceuticals, a US biotechnology firm, to develop fat-busting medicines whose main markets will be in wide-girthed America and Europe. With diminishing prospects at home, Japanese pharmaceutical companies have little option but to scour the globe for richer pickings. Sentiment : Strong Buy Rating :
 (2 Ratings) |
Male |
|
Page
1
of about
1
First
| < Prev
| Next >
| Last
|
Messages in Topic
| Subject | Author | Rating | Time of Post (ET) | ||
|---|---|---|---|---|---|
|
FYI
|
kevinmik | (2 Ratings) | 4-Nov-09 04:55 pm | ||
|
AMLN picks tough areas to develop drugs.
Most o...
|
kklausbecke... |
 
|
4-Nov-09 07:03 pm | ||
|
Ah CrapHead you have returned - shall we pick...
|
gotliebbeck | Rate it | 4-Nov-09 08:47 pm |
|
Page
1
of about
1
First
| < Prev
| Next >
| Last
|
0.06